Investigating effects of CO-OP approach on people with Multiple Sclerosis
Not Applicable
Recruiting
- Conditions
- Multiple Sclerosis.Multiple sclerosis
- Registration Number
- IRCT20210621051643N1
- Lead Sponsor
- niversity of social welfare and rehabilitation sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Diagnosis of multiple sclerosis by a neurologist
Age between 18-50 years
EDSS score between 3 and 5.5
Score more than 26 in the MoCA assessment
Exclusion Criteria
Recurrence of symptoms or the onset of a new attack during the intervention period
History of receiving CO-OP treatment or similar treatments
Existence of neurological, rheumatic or orthopedic disorders that interfere with treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Participation and Satisfaction in Activity of Daily Living (ADL). Timepoint: Before the intervention ,After the intervention, follow-up period of 3 months. Method of measurement: Canadian Occupational Performance Measure (COPM).
- Secondary Outcome Measures
Name Time Method Depression score. Timepoint: Before intervention, after intervention, 3-month follow-up period. Method of measurement: Beck Depression Inventory II (BDI-II).;Quality of life score. Timepoint: Before intervention, after intervention, 3-month follow-up period. Method of measurement: Multiple Sclerosis Impact Scale (MSIS-29).;Social participation. Timepoint: Before intervention, after intervention, 3-month follow-up period. Method of measurement: Community Integration Questionnaire (CIQ).;Intensity and effect of fatigue. Timepoint: Before intervention, after intervention, 3-month follow-up period. Method of measurement: Fatigue Impact Scale (FIS) & Fatigue Severity Scale (FSS).